Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

Recruiting now

Conditions studied: Ductal Carcinoma in Situ, Invasive Ductal Carcinoma of Female Breast

In brief

This is a multi-institutional, prospective, observational registry investigating the safety and efficacy of Accelerated Partial Breast Irradiation (APBI) using a Stereotactic Body Radiation Therapy (SBRT) delivery technique that incorporates real-time image guidance, noncoplanar fields, and respiratory tracking. The study will accrue 200 patients who will be treated to a dose of 30 Gy over the course of 5 fractions. These subjects will then have a follow up time of 5 years

Key facts

Study ID
NCT04985032
Run by
RPCR, Inc.
People needed
200
Starts
2022-08-15
Expected to finish
2027-06-01
Last updated by the study team
2022-08-05

Who can join

Age: 50 and older, up to 100. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.